Bangladesh measles deaths pass 1,000 after a 20 million-dose campaign

Bangladesh’s Directorate General of Health Services has recorded more than 1,009 measles and suspected-measles deaths since 15 March, including 100 among laboratory-confirmed patients and 909 listed as suspected. Later tallies put the dead at 1,012 and suspected cases near 189,000, with about 149,000 hospital admissions. In 2025 the same country logged 132 measles cases and zero deaths. Professor Mahmudur Rahman, former director of the Institute of Epidemiology, Disease Control and Research, told Reuters he did not know of a year with so many child deaths from the disease.

The outbreak began after immunisation slipped in 2024 and 2025, during the political break that followed Sheikh Hasina’s removal. Health Minister Sardar Husain told parliament that procurement changes in that period produced a vaccine shortage. WHO and UNICEF have pointed to the same gap. Covid-era missed doses were never fully recovered. Children in slums, migrant households and hard-to-reach districts stayed off the lists.

An emergency campaign launched in April has delivered close to 20 million measles doses. A related Vitamin A round reached about 22.3 million children. DGHS spokesman Zahid Raihan told AFP the drive still missed roughly four million children and that herd immunity was not achieved. Teams are still looking for those zero-dose names. Raihan’s phrase is the operational fact: the campaign was large and it was not large enough.

Hospital notes show where the deaths sit. One Dhaka facility had, by 23 August, 3,167 suspected cases, 537 laboratory-confirmed cases and 57 confirmed or suspected deaths. Of those 57 dead, 49 were younger than 15 months and 31 were younger than nine months, the age of the first routine measles-rubella shot in Bangladesh. Forty-seven of the 57 had received no measles vaccine. Pneumonia was written on 50 of the death records. Infants too young for the scheduled dose are taking the infection from older unvaccinated siblings and neighbours.

By early September DGHS had also reported about 187,484 infections since March in one official briefing, a figure that sits close to the later 189,000 suspected-case count. Those two ledgers use different case definitions. Laboratory-confirmed deaths remain the smaller number. Suspected deaths are the larger one because many children die of pneumonia in district hospitals before a lab result comes back. Treating only the confirmed column would understate the wave. Treating every suspected death as proven measles would overstate it. The honest range is the one DGHS now prints: four figures of dead, most of them children, in a disease that last year killed no one on the national list.

Measles is not a new pathogen in Dhaka. It is a test of lists. A child who never returns after a political shutdown, a procurement pause, or a move to a slum becomes a zero-dose case. When enough of those cases cluster, a hospital that last year saw almost no measles fills its beds with pneumonia. The 20 million doses already given will cut transmission in the districts the teams reached. They will not rewrite the first nine months of 2026 for the children who died before the van arrived.

The next useful number is not another round total. It is the count of children still unreached, by district, and the share of deaths that remain under nine months. If that infant share stays near half, the schedule itself has to move, or the campaign has to surround young infants with vaccinated contacts faster than it has so far. Bangladesh has the cold chain and the staff to do that. It did not have them in the right places when this wave began. That is why a country with a record drive is still counting deaths in four figures.